PRESS RELEASE published on 02/02/2026 at 09:00, 8 months 2 days ago Original-Research: Hoenle AG (von NuWays AG): BUY Hoenle AG's research update by NuWays AG reveals FY 24/25 results and FY 25/26 expectations, highlighting revenue and EBITDA trends across Disinfection, Adhesives, and Curing segments NuWays AG Research Update Hoenle AG FY 24/25 Results FY 25/26 Expectations
BRIEF published on 12/10/2025 at 09:05, 9 months 25 days ago Hoenle AG : Avancées stratégiques dans un contexte de marché difficile Stratégie De Croissance Prévisions Financières Technologie UV Leadership Du Marché Hoenle AG
BRIEF published on 12/10/2025 at 09:05, 9 months 25 days ago Hoenle AG: Strategic Advances Amid Challenging Market Conditions Growth Strategy Financial Forecast Market Leadership UV Technology Hoenle AG
PRESS RELEASE published on 12/10/2025 at 09:00, 9 months 25 days ago Original-Research: Hoenle AG (von NuWays AG): BUY NuWays AG updates research on Hoenle AG, recommending BUY with a target price of EUR 15.00. Hoenle leads in UV curing devices, offering solutions in adhesives, curing, and disinfection, focusing on niche markets Investment NuWays AG Research Hoenle AG UV Curing
BRIEF published on 12/03/2025 at 09:05, 10 months 1 day ago Hoenle AG Poised for Growth Amid Strategic Shifts EBITDA Margin Sales Growth Strategic Transformation Hoenle AG Disinfection Business
BRIEF published on 12/03/2025 at 09:05, 10 months 1 day ago Hoenle AG prête pour la croissance malgré des changements stratégiques Croissance Des Ventes Marge D'EBITDA Transformation Stratégique Hoenle AG Entreprise De Désinfection
PRESS RELEASE published on 12/03/2025 at 09:00, 10 months 1 day ago Original-Research: Hoenle AG (von NuWays AG): BUY Update on Hoenle AG by NuWays AG highlighting FY24/25 figures meeting guidance, FY25/26 growth expectations, strong EBITDA margin, and long-term prospects. Company poised for strategic transformation EBITDA Margin NuWays AG FY24/25 Hoenle AG FY25/26
Published on 10/03/2026 at 02:35, 1 day 21 hours ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 2 days 10 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 2 days 10 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 2 days 10 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/04/2026 at 06:05, 17 hours 52 minutes ago Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 18 hours 42 minutes ago SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 1 day 8 hours ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 2 days ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 2 days 3 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 17:45, 2 days 6 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 2 days 6 hours ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 2 days 6 hours ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 2 days 6 hours ago Aéroports de Paris SA - Calendrier financier 2027